Clinical Trial Update: Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating proton-based total marrow irradiation as conditioning before allogeneic stem cell transplantation in patients with high-ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Neoplasms
• Myelodysplastic Syndromes

Snippet

Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic | Conditions: Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML | Phase 1, Phase 2 | Status: RECRUITING